Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.

Publication ,  Journal Article
Kähler, CM; Prior, C; Gunsilius, E
Published in: Am J Respir Crit Care Med
March 2001

Duke Scholars

Published In

Am J Respir Crit Care Med

DOI

ISSN

1073-449X

Publication Date

March 2001

Volume

163

Issue

4

Start / End Page

1030 / 1031

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factors
  • Vascular Endothelial Growth Factor A
  • Sensitivity and Specificity
  • Respiratory System
  • Pseudomonas Infections
  • Prognosis
  • Pneumonia, Bacterial
  • Lymphokines
  • Humans
  • Endothelial Growth Factors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kähler, C. M., Prior, C., & Gunsilius, E. (2001). Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med, 163(4), 1030–1031. https://doi.org/10.1164/ajrccm.163.4.correspondence_b
Kähler, C. M., C. Prior, and E. Gunsilius. “Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.Am J Respir Crit Care Med 163, no. 4 (March 2001): 1030–31. https://doi.org/10.1164/ajrccm.163.4.correspondence_b.
Kähler, C. M., et al. “Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.Am J Respir Crit Care Med, vol. 163, no. 4, Mar. 2001, pp. 1030–31. Pubmed, doi:10.1164/ajrccm.163.4.correspondence_b.
Kähler CM, Prior C, Gunsilius E. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med. 2001 Mar;163(4):1030–1031.

Published In

Am J Respir Crit Care Med

DOI

ISSN

1073-449X

Publication Date

March 2001

Volume

163

Issue

4

Start / End Page

1030 / 1031

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factors
  • Vascular Endothelial Growth Factor A
  • Sensitivity and Specificity
  • Respiratory System
  • Pseudomonas Infections
  • Prognosis
  • Pneumonia, Bacterial
  • Lymphokines
  • Humans
  • Endothelial Growth Factors